aluates Reports

$ 0.0

Automative

Global Tuberculosis Diagnostic Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-5S3384

Global Tuberculosis Diagnostic Market Insights and Forecast to 2028

BUY CHAPTERS

Global Tuberculosis Diagnostic Market Research Report 2025

Code: QYRE-Auto-5S3384

Report

September 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

Hologic Corporation

Abbott

Biomerieux

Sanofi

Cepheid Inc

Hain Lifescience

Qiagen NV

Becton Dickinson

Roche

Tuberculosis Diagnostic Market Size

The global market for Tuberculosis Diagnostic was valued at US$ 2825 million in the year 2024 and is projected to reach a revised size of US$ 3592 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Tuberculosis Diagnostic Market

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Tuberculosis Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Diagnostic.

The Tuberculosis Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tuberculosis Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tuberculosis Diagnostic Market Report

Report Metric	Details
Report Name	Tuberculosis Diagnostic Market
Accounted market size in year	US$ 2825 million
Forecasted market size in 2031	US$ 3592 million
CAGR	3.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Radiographic Method Diagnostic Laboratory Methods Nucleic Acid Testing Phage Assay Detection of Latent Infection Cytokine Detection Assay Detection of Drug Resistance
Segment by Application	Infants Adults
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid, Hain Lifescience, QIAGEN
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Tuberculosis Diagnostic Market growing?

Ans: The Tuberculosis Diagnostic Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Tuberculosis Diagnostic Market size in 2031?

Ans: The Tuberculosis Diagnostic Market size in 2031 will be US$ 3592 million.

Who are the main players in the Tuberculosis Diagnostic Market report?

Ans: The main players in the Tuberculosis Diagnostic Market are Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid, Hain Lifescience, QIAGEN

What are the Application segmentation covered in the Tuberculosis Diagnostic Market report?

Ans: The Applications covered in the Tuberculosis Diagnostic Market report are Infants, Adults

What are the Type segmentation covered in the Tuberculosis Diagnostic Market report?

Ans: The Types covered in the Tuberculosis Diagnostic Market report are Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Radiographic Method

1.2.3 Diagnostic Laboratory Methods

1.2.4 Nucleic Acid Testing

1.2.5 Phage Assay

1.2.6 Detection of Latent Infection

1.2.7 Cytokine Detection Assay

1.2.8 Detection of Drug Resistance

1.3 Market by Application

1.3.1 Global Tuberculosis Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Infants

1.3.3 Adults

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tuberculosis Diagnostic Market Perspective (2020-2031)

2.2 Global Tuberculosis Diagnostic Growth Trends by Region

2.2.1 Global Tuberculosis Diagnostic Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Tuberculosis Diagnostic Historic Market Size by Region (2020-2025)

2.2.3 Tuberculosis Diagnostic Forecasted Market Size by Region (2026-2031)

2.3 Tuberculosis Diagnostic Market Dynamics

2.3.1 Tuberculosis Diagnostic Industry Trends

2.3.2 Tuberculosis Diagnostic Market Drivers

2.3.3 Tuberculosis Diagnostic Market Challenges

2.3.4 Tuberculosis Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tuberculosis Diagnostic Players by Revenue

3.1.1 Global Top Tuberculosis Diagnostic Players by Revenue (2020-2025)

3.1.2 Global Tuberculosis Diagnostic Revenue Market Share by Players (2020-2025)

3.2 Global Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Tuberculosis Diagnostic Revenue

3.4 Global Tuberculosis Diagnostic Market Concentration Ratio

3.4.1 Global Tuberculosis Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostic Revenue in 2024

3.5 Global Key Players of Tuberculosis Diagnostic Head office and Area Served

3.6 Global Key Players of Tuberculosis Diagnostic, Product and Application

3.7 Global Key Players of Tuberculosis Diagnostic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis Diagnostic Breakdown Data by Type

4.1 Global Tuberculosis Diagnostic Historic Market Size by Type (2020-2025)

4.2 Global Tuberculosis Diagnostic Forecasted Market Size by Type (2026-2031)

5 Tuberculosis Diagnostic Breakdown Data by Application

5.1 Global Tuberculosis Diagnostic Historic Market Size by Application (2020-2025)

5.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Tuberculosis Diagnostic Market Size (2020-2031)

6.2 North America Tuberculosis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Tuberculosis Diagnostic Market Size by Country (2020-2025)

6.4 North America Tuberculosis Diagnostic Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tuberculosis Diagnostic Market Size (2020-2031)

7.2 Europe Tuberculosis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Tuberculosis Diagnostic Market Size by Country (2020-2025)

7.4 Europe Tuberculosis Diagnostic Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tuberculosis Diagnostic Market Size (2020-2031)

8.2 Asia-Pacific Tuberculosis Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2020-2025)

8.4 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tuberculosis Diagnostic Market Size (2020-2031)

9.2 Latin America Tuberculosis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Tuberculosis Diagnostic Market Size by Country (2020-2025)

9.4 Latin America Tuberculosis Diagnostic Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tuberculosis Diagnostic Market Size (2020-2031)

10.2 Middle East & Africa Tuberculosis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2020-2025)

10.4 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Introduction

11.1.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2020-2025)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Hologic Corporation

11.2.1 Hologic Corporation Company Details

11.2.2 Hologic Corporation Business Overview

11.2.3 Hologic Corporation Tuberculosis Diagnostic Introduction

11.2.4 Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2020-2025)

11.2.5 Hologic Corporation Recent Development

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott Tuberculosis Diagnostic Introduction

11.3.4 Abbott Revenue in Tuberculosis Diagnostic Business (2020-2025)

11.3.5 Abbott Recent Development

11.4 Becton Dickinson

11.4.1 Becton Dickinson Company Details

11.4.2 Becton Dickinson Business Overview

11.4.3 Becton Dickinson Tuberculosis Diagnostic Introduction

11.4.4 Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2020-2025)

11.4.5 Becton Dickinson Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Tuberculosis Diagnostic Introduction

11.5.4 Roche Revenue in Tuberculosis Diagnostic Business (2020-2025)

11.5.5 Roche Recent Development

11.6 bioMerieux

11.6.1 bioMerieux Company Details

11.6.2 bioMerieux Business Overview

11.6.3 bioMerieux Tuberculosis Diagnostic Introduction

11.6.4 bioMerieux Revenue in Tuberculosis Diagnostic Business (2020-2025)

11.6.5 bioMerieux Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Tuberculosis Diagnostic Introduction

11.7.4 Sanofi Revenue in Tuberculosis Diagnostic Business (2020-2025)

11.7.5 Sanofi Recent Development

11.8 Cepheid

11.8.1 Cepheid Company Details

11.8.2 Cepheid Business Overview

11.8.3 Cepheid Tuberculosis Diagnostic Introduction

11.8.4 Cepheid Revenue in Tuberculosis Diagnostic Business (2020-2025)

11.8.5 Cepheid Recent Development

11.9 Hain Lifescience

11.9.1 Hain Lifescience Company Details

11.9.2 Hain Lifescience Business Overview

11.9.3 Hain Lifescience Tuberculosis Diagnostic Introduction

11.9.4 Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2020-2025)

11.9.5 Hain Lifescience Recent Development

11.10 QIAGEN

11.10.1 QIAGEN Company Details

11.10.2 QIAGEN Business Overview

11.10.3 QIAGEN Tuberculosis Diagnostic Introduction

11.10.4 QIAGEN Revenue in Tuberculosis Diagnostic Business (2020-2025)

11.10.5 QIAGEN Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Hologic Corporation

Abbott

Biomerieux

Sanofi

Cepheid Inc

Hain Lifescience

Qiagen NV

Becton Dickinson

Roche

List of Tables

Table 1. Global Tuberculosis Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Radiographic Method

Table 3. Key Players of Diagnostic Laboratory Methods

Table 4. Key Players of Nucleic Acid Testing

Table 5. Key Players of Phage Assay

Table 6. Key Players of Detection of Latent Infection

Table 7. Key Players of Cytokine Detection Assay

Table 8. Key Players of Detection of Drug Resistance

Table 9. Global Tuberculosis Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Tuberculosis Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Tuberculosis Diagnostic Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Tuberculosis Diagnostic Market Share by Region (2020-2025)

Table 13. Global Tuberculosis Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Tuberculosis Diagnostic Market Share by Region (2026-2031)

Table 15. Tuberculosis Diagnostic Market Trends

Table 16. Tuberculosis Diagnostic Market Drivers

Table 17. Tuberculosis Diagnostic Market Challenges

Table 18. Tuberculosis Diagnostic Market Restraints

Table 19. Global Tuberculosis Diagnostic Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Tuberculosis Diagnostic Market Share by Players (2020-2025)

Table 21. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2024)

Table 22. Ranking of Global Top Tuberculosis Diagnostic Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Tuberculosis Diagnostic Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Tuberculosis Diagnostic, Headquarters and Area Served

Table 25. Global Key Players of Tuberculosis Diagnostic, Product and Application

Table 26. Global Key Players of Tuberculosis Diagnostic, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Tuberculosis Diagnostic Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Tuberculosis Diagnostic Revenue Market Share by Type (2020-2025)

Table 30. Global Tuberculosis Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Tuberculosis Diagnostic Revenue Market Share by Type (2026-2031)

Table 32. Global Tuberculosis Diagnostic Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Tuberculosis Diagnostic Revenue Market Share by Application (2020-2025)

Table 34. Global Tuberculosis Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Tuberculosis Diagnostic Revenue Market Share by Application (2026-2031)

Table 36. North America Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Tuberculosis Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Tuberculosis Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Tuberculosis Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Tuberculosis Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Tuberculosis Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Tuberculosis Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Tuberculosis Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 51. Thermo Fisher Scientific Company Details

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific Tuberculosis Diagnostic Product

Table 54. Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2020-2025) & (US$ Million)

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Hologic Corporation Company Details

Table 57. Hologic Corporation Business Overview

Table 58. Hologic Corporation Tuberculosis Diagnostic Product

Table 59. Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2020-2025) & (US$ Million)

Table 60. Hologic Corporation Recent Development

Table 61. Abbott Company Details

Table 62. Abbott Business Overview

Table 63. Abbott Tuberculosis Diagnostic Product

Table 64. Abbott Revenue in Tuberculosis Diagnostic Business (2020-2025) & (US$ Million)

Table 65. Abbott Recent Development

Table 66. Becton Dickinson Company Details

Table 67. Becton Dickinson Business Overview

Table 68. Becton Dickinson Tuberculosis Diagnostic Product

Table 69. Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2020-2025) & (US$ Million)

Table 70. Becton Dickinson Recent Development

Table 71. Roche Company Details

Table 72. Roche Business Overview

Table 73. Roche Tuberculosis Diagnostic Product

Table 74. Roche Revenue in Tuberculosis Diagnostic Business (2020-2025) & (US$ Million)

Table 75. Roche Recent Development

Table 76. bioMerieux Company Details

Table 77. bioMerieux Business Overview

Table 78. bioMerieux Tuberculosis Diagnostic Product

Table 79. bioMerieux Revenue in Tuberculosis Diagnostic Business (2020-2025) & (US$ Million)

Table 80. bioMerieux Recent Development

Table 81. Sanofi Company Details

Table 82. Sanofi Business Overview

Table 83. Sanofi Tuberculosis Diagnostic Product

Table 84. Sanofi Revenue in Tuberculosis Diagnostic Business (2020-2025) & (US$ Million)

Table 85. Sanofi Recent Development

Table 86. Cepheid Company Details

Table 87. Cepheid Business Overview

Table 88. Cepheid Tuberculosis Diagnostic Product

Table 89. Cepheid Revenue in Tuberculosis Diagnostic Business (2020-2025) & (US$ Million)

Table 90. Cepheid Recent Development

Table 91. Hain Lifescience Company Details

Table 92. Hain Lifescience Business Overview

Table 93. Hain Lifescience Tuberculosis Diagnostic Product

Table 94. Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2020-2025) & (US$ Million)

Table 95. Hain Lifescience Recent Development

Table 96. QIAGEN Company Details

Table 97. QIAGEN Business Overview

Table 98. QIAGEN Tuberculosis Diagnostic Product

Table 99. QIAGEN Revenue in Tuberculosis Diagnostic Business (2020-2025) & (US$ Million)

Table 100. QIAGEN Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Tuberculosis Diagnostic Picture

Figure 2. Global Tuberculosis Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Tuberculosis Diagnostic Market Share by Type: 2024 VS 2031

Figure 4. Radiographic Method Features

Figure 5. Diagnostic Laboratory Methods Features

Figure 6. Nucleic Acid Testing Features

Figure 7. Phage Assay Features

Figure 8. Detection of Latent Infection Features

Figure 9. Cytokine Detection Assay Features

Figure 10. Detection of Drug Resistance Features

Figure 11. Global Tuberculosis Diagnostic Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Tuberculosis Diagnostic Market Share by Application: 2024 VS 2031

Figure 13. Infants Case Studies

Figure 14. Adults Case Studies

Figure 15. Tuberculosis Diagnostic Report Years Considered

Figure 16. Global Tuberculosis Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Tuberculosis Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Tuberculosis Diagnostic Market Share by Region: 2024 VS 2031

Figure 19. Global Tuberculosis Diagnostic Market Share by Players in 2024

Figure 20. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostic Revenue in 2024

Figure 22. North America Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Tuberculosis Diagnostic Market Share by Country (2020-2031)

Figure 24. United States Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Tuberculosis Diagnostic Market Share by Country (2020-2031)

Figure 28. Germany Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Tuberculosis Diagnostic Market Share by Region (2020-2031)

Figure 36. China Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Tuberculosis Diagnostic Market Share by Country (2020-2031)

Figure 44. Mexico Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Tuberculosis Diagnostic Market Share by Country (2020-2031)

Figure 48. Turkey Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Tuberculosis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnostic Business (2020-2025)

Figure 52. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostic Business (2020-2025)

Figure 53. Abbott Revenue Growth Rate in Tuberculosis Diagnostic Business (2020-2025)

Figure 54. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostic Business (2020-2025)

Figure 55. Roche Revenue Growth Rate in Tuberculosis Diagnostic Business (2020-2025)

Figure 56. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostic Business (2020-2025)

Figure 57. Sanofi Revenue Growth Rate in Tuberculosis Diagnostic Business (2020-2025)

Figure 58. Cepheid Revenue Growth Rate in Tuberculosis Diagnostic Business (2020-2025)

Figure 59. Hain Lifescience Revenue Growth Rate in Tuberculosis Diagnostic Business (2020-2025)

Figure 60. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostic Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Tuberculosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tuberculosis Vaccines Market Research Report 2024

Global Tuberculosis TB Detection Market Research Report 2024

Global Mycobacterium Tuberculosis Testing Market Research Report 2024

Tuberculosis Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tuberculosis Vaccination Market Research Report 2025

TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global BCG and Tuberculosis Vaccine Market Research Report 2025

Tuberculosis Testing and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global TB Disease Vaccine Market Research Report 2025

BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

VPM1002 Tuberculosis BCG Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti tuberculosis Therapeutics Market Insights Forecast to 2030

Latent Tuberculosis Infection Screening Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global BCG Vaccine Market Insights Forecast to 2030

Global Latent TB Detection Market Research Report 2024

Global Mycobacterium Tuberculosis Detection Kits Market Research Report 2025

Global BCG Vaccination Market Research Report 2025

Global Mycobacterium Infections Treatment Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions